Literature DB >> 15094140

Differential induction and regulation of matrix metalloproteinases in osteoarthritic tissue and fluid synovial fibroblasts.

S Fuchs1, A Skwara, M Bloch, B Dankbar.   

Abstract

OBJECTIVES: To investigate the secretion profiles of matrix metalloproteinases (MMP) and their inhibitors (TIMP) in synovial fluid-derived fibroblasts and to compare them with those of tissue-derived fibroblasts.
METHODS: Fibroblast cultures established from synovial tissues (TSC) and fluids (FSC) of the same OA patients were stimulated with tumor necrosis factor(TNF)-alpha, interleukin(IL)-1alpha, IL-1beta, IL-6 and a combination of TNFalpha and IL-1beta. Cocultures of fibroblasts and cartilage were stimulated either with the cytokine combination or with osteoarthritic synovial fluid. Secretion of MMP-1, MMP-3, MMP-8, MMP-13, TIMP-1, and TIMP-2 was measured by enzyme-linked immunosorbent assay. Gelatin zymography and immunoblotting were performed to demonstrate enzyme activity.
RESULTS: TNFalpha, IL-1alpha, and IL-1beta led to marked increases in MMP-1 and MMP-3 release (up to 4.2-fold and 547-fold, respectively) by synovial fibroblasts, whereas secretion of MMP-13 was induced by concomitant administration of TNFalpha and IL-1beta. Expression of intracellular MMP-8 was stimulated by cytokines, but adhesion of synovial fibroblasts to cartilage was required for the release. Throughout the study, significantly higher levels of secreted MMPs were observed in stimulated FSC compared to TSC cultures. Furthermore, increases in MMP secretion were not accompanied by increases in secreted TIMP-1 and TIMP-2, resulting in marked imbalances between enzyme and inhibitor levels.
CONCLUSIONS: The results provide strong evidence for a significant impact of synovial-derived MMPs on cartilage destruction in OA. In this context, fibroblasts present in the synovial fluid appeared to play an outstanding role.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15094140     DOI: 10.1016/j.joca.2004.02.005

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  24 in total

1.  Transient Receptor Potential Ankyrin 1 (TRPA1) Mediates Lipopolysaccharide (LPS)-Induced Inflammatory Responses in Primary Human Osteoarthritic Fibroblast-Like Synoviocytes.

Authors:  Songjiang Yin; Peimin Wang; Runlin Xing; Linrui Zhao; Xiaochen Li; Li Zhang; Yancheng Xiao
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

2.  Potential role of fibroblast-like synoviocytes in joint damage induced by Brucella abortus infection through production and induction of matrix metalloproteinases.

Authors:  Romina Scian; Paula Barrionuevo; Guillermo H Giambartolomei; Emilio A De Simone; Silvia I Vanzulli; Carlos A Fossati; Pablo C Baldi; M Victoria Delpino
Journal:  Infect Immun       Date:  2011-07-05       Impact factor: 3.441

3.  [Manifestation of generalized osteoarthritis in a genealogically investigated population].

Authors:  U Irlenbusch; L Forke; U Fuhrmann; U Lorenz; A Stechel
Journal:  Z Rheumatol       Date:  2010-08       Impact factor: 1.372

4.  MMPs are less efficient than ADAMTS5 in cleaving aggrecan core protein.

Authors:  Michaela Durigova; Hideaki Nagase; John S Mort; Peter J Roughley
Journal:  Matrix Biol       Date:  2010-11-03       Impact factor: 11.583

Review 5.  Changes in the myocardial interstitium and contribution to the progression of heart failure.

Authors:  Shaina R Eckhouse; Francis G Spinale
Journal:  Heart Fail Clin       Date:  2012-01       Impact factor: 3.179

6.  Expression of matrix metalloproteinases 1, 3, and 9 in differing extents of tendon retraction in the torn rotator cuff.

Authors:  Stefan Lakemeier; Juliane Braun; Turgay Efe; Christian Foelsch; Eleni Archontidou-Aprin; Susanne Fuchs-Winkelmann; Juergen R J Paletta; Markus D Schofer
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-01-11       Impact factor: 4.342

7.  Urokinase plasminogen activator system in synovial fibroblasts from osteoarthritis patients: modulation by inflammatory mediators and neuropeptides.

Authors:  Selene Pérez-García; Mar Carrión; Rebeca Jimeno; Ana M Ortiz; Isidoro González-Álvaro; Julián Fernández; Rosa P Gomariz; Yasmina Juarranz
Journal:  J Mol Neurosci       Date:  2013-12-07       Impact factor: 3.444

8.  Monitoring of therapeutic efficacy in a patient with RS₃PE syndrome by serologic variables and radiographic methods.

Authors:  Shin-ya Kawashiri; Michiko Nakano; Atsushi Kawakami; Katsumi Eguchi
Journal:  Rheumatol Int       Date:  2009-10-07       Impact factor: 2.631

9.  Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells.

Authors:  Sybille Franke; Manfred Sommer; Christiane Rüster; Tzvetanka Bondeva; Julia Marticke; Gunther Hofmann; Gert Hein; Gunter Wolf
Journal:  Arthritis Res Ther       Date:  2009-09-07       Impact factor: 5.156

10.  Gene expression and activity of cartilage degrading glycosidases in human rheumatoid arthritis and osteoarthritis synovial fibroblasts.

Authors:  Mária Pásztói; György Nagy; Pál Géher; Tamás Lakatos; Kálmán Tóth; Károly Wellinger; Péter Pócza; Bence György; Marianna C Holub; Agnes Kittel; Krisztina Pálóczy; Mercédesz Mazán; Péter Nyirkos; András Falus; Edit I Buzas
Journal:  Arthritis Res Ther       Date:  2009-05-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.